Details of the Drug

General Information of Drug (ID: DM4I02O)

Drug Name
NJA-730
Indication
Disease Entry ICD 11 Status REF
Graft-versus-host disease 4B24 Phase 1 [1]
Drug Type
Antisense oligonucleotide
Cross-matching ID
TTD ID
D1BT2M

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
CD40 messenger RNA (CD40 mRNA) TT1ERKL TNR5_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of NapaJen Pharma.